GPS III SINGLE KIT W/30ML ACDA N/A 800-1003A

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a consumer report with the FDA on 2016-11-30 for GPS III SINGLE KIT W/30ML ACDA N/A 800-1003A manufactured by Biomet Biologics.

Event Text Entries

[61186669] Current information is insufficient to permit a conclusion as to the cause of the event. Review of device history records show the lot released with no recorded anomaly or deviation. (b)(4). There are warnings in the package insert that state that this type of event can occur: under possible adverse effects, number 3 states, "early or late postoperative infection. "
Patient Sequence No: 1, Text Type: N, H10


[61186670] Legal counsel for the patient reported that the patient underwent a drainage procedure approximately 18 days after an arthroscopic surgical procedure in which biological material was utilized due to infection, pain, abscess formation, wound drainage, erythema, and redness and swelling of the left shoulder. Legal counsel additionally alleges that the patient's rotator cuff was noted to be friable upon examination during the drainage procedure. This report is based on allegations set forth in plaintiff? S complaint, and the allegations contained therein are unverified.
Patient Sequence No: 1, Text Type: D, B5


[63721578] This follow-up report is being filed to relay additional information, which was unknown at the time of the initial medwatch. Review of sterilization certification confirms device was sterilized in accordance with (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[68130115] This follow-up report is being filed to relay additional and corrected information, which was unknown at the time of the initial medwatch. Concomitant medical product - mixing applicator tip, catalog#: 800-0252, lot#:129422; biomet biologics spray kit. Catalog#: 800-0250, lot#: 132592.
Patient Sequence No: 1, Text Type: N, H10


[76091450] This follow-up report is being submitted to relay additional information. The following sections were updated/corrected: n/a, device is a solution and not an explantable device reported event was confirmed by review of provided medical record documentation. No medical records received; however, notes were provided with the legal paperwork which include a review of medical records. At 5 days post op, the patient complained of pain and presented to the emergency room. Medication was given to manage the pain. At 7 days post op, the patient presented to the surgeon's office and was prescribed additional pain medication. At 10 days post op, the patient presented to the emergency room due to pain and fever. A ct examination was performed and found enhanced fluid collection that is consistent with wound infection, suspicious for abscess. The records indicate that the surgeon ordered no antibiotics be administered at this that time. At 11 days post op, the patient was seen by a second physician and the patient was discharged. At 12 days post op, the surgeon prescribed oral antibiotics due to complaints of pain, fever, and drainage from the surgical site. At 13 days post op, patient was seen by the initial surgeon who noted purulent tissue and chose to continue oral antibiotics. At 16 days post op, surgeon was again contacted due to complaints of wound draining puss. At 18 days post op, the wound was drained. Purulent material was drained and the tissue of the joint was found to be friable and non-viable rotator cuff tissue broke apart during the procedure. At 112 days post op, the patient was revised due to the failed arthroscopic surgery. Device history record (dhr) was reviewed and no discrepancies were found. Further review of reported product found it related to a supplier recall performed in 2016. A definitive root cause could not be determined, as it cannot be confirmed the recalled product caused or contributed to the reported event. Corrective actions were initiated for the recalled devices. If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly. Zimmer biomet will continue to monitor for trends.
Patient Sequence No: 1, Text Type: N, H10


[78992992] (b)(4). Implant and explant dates should be left blank as it was determined that this complaint product should not be marked as an implant.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number0001825034-2016-04955
MDR Report Key6137143
Report SourceCONSUMER
Date Received2016-11-30
Date of Report2017-06-05
Date of Event2015-01-20
Date Mfgr Received2017-05-26
Device Manufacturer Date2014-11-14
Date Added to Maude2016-11-30
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationATTORNEY
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. CHRISTINA ARNT
Manufacturer Street56 E. BELL DR.
Manufacturer CityWARSAW IN 46582
Manufacturer CountryUS
Manufacturer Postal46582
Manufacturer Phone5745273773
Manufacturer G1BIOMET ORTHOPEDICS
Manufacturer Street56 E. BELL DRIVE
Manufacturer CityWARSAW IN 46582
Manufacturer CountryUS
Manufacturer Postal Code46582
Single Use3
Previous Use Code3
Removal Correction NumberB-0729-16, B-0730-16
Event Type3
Type of Report3

Device Details

Brand NameGPS III SINGLE KIT W/30ML ACDA
Generic NameSUPPLIES, BLOOD-BANK
Product CodeKSS
Date Received2016-11-30
Model NumberN/A
Catalog Number800-1003A
Lot Number402274
ID NumberN/A
Device Expiration Date2016-12-31
OperatorPHYSICIAN
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerBIOMET BIOLOGICS
Manufacturer Address56 E. BELL DRIVE WARSAW IN 46582 US 46582


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention 2016-11-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.